compound 3 [Uddin et al., 2020]   Click here for help

GtoPdb Ligand ID: 10701

PDB Ligand
Compound class: Synthetic organic
Comment: Compound 3 is reported as a substrate selective inhibitor of cyclooxygenase-2 (COX-2) [1]. It preferentially inhibits conversion (by oxygenation) of the endocannabinoid 2-arachidonoylglycerol (2-AG) to prostaglandin glyceryl ester (PG-G) compared to oxygenation of arachidonic acid (AA) into prostaglandins, which is predicted to increase endocannabinoid levels in the brain and mediate anti-stress/anti-anxiety effects.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 26.52
Molecular weight 338.12
XLogP 4.9
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ccc2c(c1)c1CCN=C(c1n2Cc1ccc(cc1)Cl)C
Isomeric SMILES COc1ccc2c(c1)c1CCN=C(c1n2Cc1ccc(cc1)Cl)C
InChI InChI=1S/C20H19ClN2O/c1-13-20-17(9-10-22-13)18-11-16(24-2)7-8-19(18)23(20)12-14-3-5-15(21)6-4-14/h3-8,11H,9-10,12H2,1-2H3
InChI Key SRMUEFRMPPZYOH-UHFFFAOYSA-N
References
1. Uddin MJ, Xu S, Crews BC, Ghebreselasie K, Banerjee S, Marnett LJ. (2020)
Harmaline Analogs as Substrate-Selective Cyclooxygenase-2 Inhibitors.
ACS Med Chem Lett, ARTICLES ASAP. DOI: 10.1021/acsmedchemlett.9b00555